Full text is available at the source.
Abstract
The impact of glucagon-like peptide-1 receptor agonists on diabetic retinopathy progression is not yet clear.
- Diabetic retinopathy is a major cause of vision impairment in diabetics.
- The role of glucagon-like peptide-1 receptor agonists in influencing the progression of diabetic retinopathy is still uncertain.
- This review and meta-analysis seek to clarify the relationship between GLP-1RA therapy and diabetic retinopathy progression.
Simplified